May 21 (Reuters) - Sanofi SA:

* PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC.,

ADDING A NEW INVESTIGATIONAL MEDICINE TO TREAT ALZHEIMER'S

DISEASE TO THE NEUROLOGY PIPELINE

* SANOFI SA - VIGIL SHAREHOLDERS TO RECEIVE $2 CVR PER SHARE

* SANOFI SA - ACQUISITION WILL NOT IMPACT SANOFI'S 2025

FINANCIAL

GUIDANCE

* SANOFI SA - MADE $40 MILLION STRATEGIC INVESTMENT IN VIGIL

* SANOFI SA - DEAL EXPECTED TO CLOSE IN Q3 2025

* SANOFI SA - TO BUY VIGIL FOR $8 PER SHARE, EQUITY VALUE

$470

MILLION

Source text:

Further company coverage: